Pacira (PCRX) BioSciences announced the granting of inducement awards on April 2, 2025 to 18 new employees under Pacira’s Amended and Restated 2014 Inducement Plan as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors without stockholder approval.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira price target raised to $28 from $25 at Truist
- Positive Outlook for Pacira Pharmaceuticals Amid Exparel Settlement and Strategic Growth Initiatives
- Pacira price target raised to $26 from $22 at RBC Capital
- Pacira price target raised to $65 from $48 at H.C. Wainwright
- Closing Bell Movers: Levi Strauss up 8% on earnings, futures find footing